Eculizumab treatment in paediatric patients diagnosed with aHUS after haematopoietic stem cell transplantation: a HSCT-TMA case series from Japanese aHUS post-marketing surveillance
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Eculizumab treatment in paediatric patients diagnosed with aHUS after haematopoietic stem cell transplantation: a HSCT-TMA case series from Japanese aHUS post-marketing surveillance ; day:15 ; month:12 ; year:2023 ; pages:1-10
Bone marrow transplantation ; (15.12.2023), 1-10
- Creator
-
Ito, Shuichi
Saito, Atsuro
Sakurai, Ayako
Watanabe, Kenichiro
Karakawa, Shuhei
Miyamura, Takako
Yokosuka, Tomoko
Ueki, Hideaki
Goto, Hiroaki
Yagasaki, Hiroshi
Kinoshita, Mariko
Ozeki, Michio
Yokoyama, Norifumi
Teranishi, Hirofumi
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41409-023-02161-7
- URN
-
urn:nbn:de:101:1-2024030107574254291338
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ito, Shuichi
- Saito, Atsuro
- Sakurai, Ayako
- Watanabe, Kenichiro
- Karakawa, Shuhei
- Miyamura, Takako
- Yokosuka, Tomoko
- Ueki, Hideaki
- Goto, Hiroaki
- Yagasaki, Hiroshi
- Kinoshita, Mariko
- Ozeki, Michio
- Yokoyama, Norifumi
- Teranishi, Hirofumi
- SpringerLink (Online service)
Other Objects (12)
Pregnancy-triggered atypical hemolytic uremic syndrome (aHUS): a Global aHUS Registry analysis
The global aHUS registry: methodology and initial patient characteristics
The global aHUS registry: methodology and initial patient characteristics
Ahus
Ahus
Charakterisierung von Patienten mit atypischem hämolytisch-urämischen Syndrom (aHUS) in Deutschland : Daten aus dem globalen aHUS-Register
Konsulate - Länder: Ahus
Different approaches to long-term treatment of aHUS due to MCP mutations: a multicenter analysis
Functional similarity of ABP 959 and eculizumab in simulated serum models of aHUS and NMOSD
Different approaches to long-term treatment of aHUS due to MCP mutations: a multicenter analysis
Exploratory Prognostic Biomarkers of Complement-Mediated Thrombotic Microangiopathy (CM-TMA) in Adults with Atypical Hemolytic Uremic Syndrome (aHUS): Analysis of a Phase III Study of Ravulizumab
Rat der Stadt Ahus
Pregnancy-triggered atypical hemolytic uremic syndrome (aHUS): a Global aHUS Registry analysis
The global aHUS registry: methodology and initial patient characteristics
The global aHUS registry: methodology and initial patient characteristics
Ahus
Ahus
Charakterisierung von Patienten mit atypischem hämolytisch-urämischen Syndrom (aHUS) in Deutschland : Daten aus dem globalen aHUS-Register
Konsulate - Länder: Ahus
Different approaches to long-term treatment of aHUS due to MCP mutations: a multicenter analysis
Functional similarity of ABP 959 and eculizumab in simulated serum models of aHUS and NMOSD
Different approaches to long-term treatment of aHUS due to MCP mutations: a multicenter analysis
Exploratory Prognostic Biomarkers of Complement-Mediated Thrombotic Microangiopathy (CM-TMA) in Adults with Atypical Hemolytic Uremic Syndrome (aHUS): Analysis of a Phase III Study of Ravulizumab
Rat der Stadt Ahus
Pregnancy-triggered atypical hemolytic uremic syndrome (aHUS): a Global aHUS Registry analysis
The global aHUS registry: methodology and initial patient characteristics
The global aHUS registry: methodology and initial patient characteristics
Ahus
Ahus
Charakterisierung von Patienten mit atypischem hämolytisch-urämischen Syndrom (aHUS) in Deutschland : Daten aus dem globalen aHUS-Register
Konsulate - Länder: Ahus
Different approaches to long-term treatment of aHUS due to MCP mutations: a multicenter analysis
Functional similarity of ABP 959 and eculizumab in simulated serum models of aHUS and NMOSD
Different approaches to long-term treatment of aHUS due to MCP mutations: a multicenter analysis
Exploratory Prognostic Biomarkers of Complement-Mediated Thrombotic Microangiopathy (CM-TMA) in Adults with Atypical Hemolytic Uremic Syndrome (aHUS): Analysis of a Phase III Study of Ravulizumab